Patent · US Active

Esters of DCPLA and methods of treatment using the same

US9163032B2 · kind B2 · utility

3Cited by
9References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 13, 2012
Grant dateOct 20, 2015
Priority date
Expiry dateNov 13, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/16
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present disclosure relates to esters of 8-[2-(2-pentyl-cyclopropylmethyl)cyclopropyl]-octanoic acid (“DCPLA”). The disclosure further relates to compositions, kits, and methods for treatment using the esters.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.